Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Lipoglycopeptide Antibacterial [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
DALBAVANCIN 1,107 54 4.9% 288 47 61.0 yrs 46.7%
ORITAVANCIN 884 29 3.3% 157 37 55.9 yrs 52.2%
ORITAVANCIN DIPHOSPHATE 276 4 1.4% 27 5 58.5 yrs 39.2%
TELAVANCIN 82 3 3.7% 25 1 50.0 yrs 38.8%

Head-to-Head Comparisons

DALBAVANCIN vs ORITAVANCIN DALBAVANCIN vs ORITAVANCIN DIPHOSPHATE DALBAVANCIN vs TELAVANCIN ORITAVANCIN vs ORITAVANCIN DIPHOSPHATE ORITAVANCIN vs TELAVANCIN ORITAVANCIN DIPHOSPHATE vs TELAVANCIN
← Back to Lipoglycopeptide Antibacterial [EPC] Class side effects →